Colorado joined Oregon in legalizing psilocybin therapy, though the drug remains illegal in most other states and federally.

An international team of researchers conducted a clinical trial on 493 adults whose major depression hadn't previously ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...

Neumora Therapeutics stock collapsed Thursday after its experimental depression treatment failed in the first of three ...

Launched this year, Miami-based Hope Therapeutics is a developer of NRX-100, a ketamine drug used to treat suicidal ...

Neumora Therapeutics Inc. (NASDAQ: NMRA) nosedived by more than 80 percent during pre-market trading following disappointing ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Neumora Therapeutics Inc.'s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.

Colorado joined Oregon in legalizing psilocybin therapy, though the drug remains illegal in most other states and federally.

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

The clinical-stage biopharmaceutical company said the Phase 3 study didn't demonstrate a statistically significant improvement on the primary endpoint of change from baseline in a scale that measures ...